The chemical class known as neurexin II activators encompasses a range of compounds that can potentially upregulate or enhance the activity of neurexin II, a protein that plays a crucial role in synaptic formation and maintenance in the nervous system. These activators are not a homogeneous group but rather a collection of diverse molecules that may impact neurexin II through various mechanisms. The term 'activator' in this context typically refers to substances that increase the expression, stability, or functional activity of neurexin II. The increase in expression could be due to the enhanced transcription of the neurexin II gene, stabilization of its mRNA, or by hindering the degradation pathways that would normally break down the neurexin II protein. Furthermore, some activators might bind directly to neurexin II, changing its conformation in a way that promotes its interaction with other synaptic proteins, such as neuroligins, thereby influencing synaptic plasticity and function.
Within this class, the molecules might act at the genetic level to promote gene expression, or they may function post-translationally to prevent protein degradation or facilitate proper protein folding and trafficking to the synapse. The changes brought about by these activators can affect the synaptic architecture by modulating the abundance of neurexin II at synaptic junctions. This modulation can influence the synapse's ability to adapt to changes, a fundamental process for synaptic signaling and plasticity. Neurexin II activators could potentially affect the presynaptic neuron's ability to release neurotransmitters in response to an action potential, which in turn might affect the overall synaptic transmission efficacy. Since neurexin II is implicated in the precise connection between neurons, the activators have a significant role in ensuring the integrity of these connections, potentially affecting the complex network of neuronal communication and the plasticity of neural circuits.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Podría aumentar la transcripción de la neurexina II al inducir la acetilación de histonas, creando así un estado de cromatina más accesible alrededor de su gen. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Podría regular al alza la neurexina II reduciendo la metilación en el promotor de su gen, potenciando la transcripción. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Puede aumentar indirectamente los niveles de neurexina II al inhibir la degradación mediada por el proteasoma, si la neurexina II es una diana del proteasoma. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Podría modular la expresión de la neurexina II influyendo en las vías de señalización intracelular que regulan la transcripción génica. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Podría influir en la expresión de la neurexina II modulando las vías de señalización intracelular implicadas en la función neuronal. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
Afecta potencialmente a la expresión de neurexina II a través de cambios en la fluidez de la membrana y las vías de señalización asociadas. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Pourrait affecter l'expression de la neurexine II en modifiant la composition de la membrane neuronale et les cascades de signalisation cellulaire. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Podría regular la expresión de neurexina II como parte de su papel en la modulación de la expresión génica durante la diferenciación neuronal. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Podría regular al alza la neurexina II a través de la activación de la proteína quinasa C, implicada en la regulación de la expresión génica. | ||||||